|
BARBORO P.-REPACI E.-FERRARI N.-RUBAGOTTI A.-BOCCARDO F.-BALBI C.
Androgen receptor and heterogeneous nuclear ribonucleoprotein K
colocalize in the nucleoplasm and are modulated by bicalutamide
and 4/hydroxy/tamoxifen in prostatic cancer cell lines.
Prostate 71:1466/1479, 2011
PubMed Abstract
CATELLANI S.-PIERRI I.-GOBBI M.-POGGI A.-ZOCCHI M.R.
Imatinib treatment induces CD5+ B lymphocytes and IgM natural
antibodies with anti leukemic reactivity in patients with chronic
myelogenous leukemia.
PLoS One 6(4):e18925;1/e18925;9, 2011
PubMed Abstract
GHIO M.-CONTINI P.-NEGRINI S.-MAZZEI C.-ZOCCHI M.R.-POGGI A.
Down regulation of human natural killer cell mediated cytolysis
induced by blood transfusion: role of transforming growth factor
beta(1), soluble Fas ligand, and soluble Class I human leukocyte
antigen.
Transfusion 51:1567/1573, 2011
PubMed Abstract
MIRABELLA T.-CILLI M.-CARLONE S.-CANCEDDA R.-GENTILI C.
Amniotic liquid derived stem cells as reservoir of secreted
angiogenic factors capable of stimulating neo arteriogenesis in an
ischemic model.
Biomaterials 32:3689/3699, 2011
PubMed Abstract
MIRABELLA T.-POGGI A.-SCARANARI M.-MOGNI M.-LITUANIA M.-BALDO C.-
CANCEDDA R.-GENTILI C.
Recruitment of host's progenitor cells to sites of human amniotic
fluid stem cells implantation.
Biomaterials 32:4218/4227, 2011
PubMed Abstract
ROPOLO M.-CAPPELLI E.-FORESTA M.-POGGI A.-PROIETTI DE SANTIS L.-
FROSINA G.
Defective resolution of pH2AX foci and enhanced DNA breakage in
ionizing radiation treated cockayne syndrome B cells.
IUBMB Life 63(4):272/276, 2011
PubMed Abstract
BENELLI R.-MONTEGHIRFO S.-VENE' R.-TOSETTI F.-FERRARI N.
The chemopreventive retinoid 4HPR impairs prostate cancer cell
migration and invasion by interfering with FAK/AKT/GSK3beta
pathway and beta catenin stability.
Mol. Cancer 9:142;1/142;13, 2010
PubMed Abstract
FAVONI R.E.-PATTAROZZI A.-LO CASTO M.-BARBIERI F.-GATTI M.-PALEARI
L.-BAJETTO A.-PORCILE C.-GAUDINO G.-MUTTI L.-CORTE G.-FLORIO T.
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to
inhibit pleural mesothelioma cell proliferation.
Curr. Cancer Drug Targets 10:176/191, 2010
PubMed Abstract
MUSSO A.-ZOCCHI M.R.-POGGI A.
Relevance of the mevalonate biosynthetic pathway in the regulation
of bone marrow mesenchymal stromal cell mediated effects on T cell
proliferation and B cell survival.
Haematologica 96(1):16/23, 2011 - Epub Sep 30, 2010
PubMed Abstract
POGGI A.-PREVOSTO C.-CATELLANI S.-ROCCO I.-GARUTI A.-ZOCCHI M.R.
Engagement of CD31 delivers an activating signal that contributes
to the survival of chronic lymphocytic leukaemia cells.
Br. J. Haematol. 151:252/264, 2010
PubMed Abstract
POGGI A.-ZANCOLLI M.-BOERO S.-CATELLANI S.-MUSSO A.-ZOCCHI M.R.
Differential survival of gammadeltaT cells, alphabetaT cells, and
NK cells upon engagement of NKG2D by NKG2DL expressing leukemic cells.
Int. J. Cancer 129:387/396, 2011 - Epub Sep 17, 2010
PubMed Abstract
BARBORO P.-REPACI E.-RUBAGOTTI A.-SALVI S.-BOCCARDO S.-SPINA B.-
TRUINI M.-INTROINI C.-PUPPO P.-FERRARI N.-CARMIGNANI G.-BOCCARDO
F.-BALBI C.
Heterogeneous nuclear ribonucleoprotein K: altered pattern of
expression associated with diagnosis and prognosis of prostate
cancer.
Br. J. Cancer 100:1608/1616, 2009
PubMed Abstract
BENELLI R.-FERRARI N.
Angiogenesis inhibition: state of art, forgotten strategies and
new perspectives in cancer therapy.
Curr. Cancer Ther. Rev. 5:203/216, 2009
BENELLI R.-MONTEGHIRFO S.-BALBI C.-BARBORO P.-FERRARI N.
Novel antivascular efficacy of metronomic docetaxel therapy in
prostate cancer: hnRNP K as a player.
Int. J. Cancer 124:2989/2996, 2009
PubMed Abstract
BRUZZONE S.-FRUSCIONE F.-MORANDO S.-FERRANDO T.-POGGI A.-GARUTI A.-
D'URSO A.-SELMO M.-BENVENUTO F.-CEA M.-ZOPPOLI G.-MORAN E.-SONCINI
D.-BALLESTRERO A.-SORDAT B.-PATRONE F.-MOSTOSLAVSKY R.-UCCELLI A.-
NENCIONI A.
Catastrophic NAD+ depletion in activated T lymphocytes through
nampt inhibition reduces demyelination and disability in EAE.
PLoS One 4:e7897;1/e7897;14, 2009
PubMed Abstract
FENOGLIO D.-POGGI A.-CATELLANI S.-BATTAGLIA F.-FERRERA A.-SETTI M.-
MURDACA G.-ZOCCHI M.
Vdelta1 T lymphocytes producing IFN/gamma and IL/17 are expanded
in HIV/1 infected patients and respond to Candida albicans.
Blood 113:6611/6618, 2009
PubMed Abstract
FORESTA M.-ROPOLO M.-DEGAN P.-PETTINATI I.-KOW Y.-DAMONTE G.-POGGI
A.-FROSINA G.
Defective repair of 5/hydroxy/2'/deoxycytidine in Cockayne
syndrome cells and its complementation by Escherichia coli
formamidopyrimidine DNA glycosylase and endonuclease III.
Free Radic. Biol. Med. 48:681/690, 2010 - Epub Dec 21, 2009
PubMed Abstract
GHIO M.-CONTINI P.-NEGRINI S.-BOERO S.-MUSSO A.-POGGI A.
Soluble HLA/I mediated secretion of TGF/beta1 by human NK cells
and consequent downregulation of antitumor cytolytic activity.
Eur. J. Immunol. 39:3459/3468, 2009
PubMed Abstract
GRIFFERO F.-DAGA A.-MARUBBI D.-CAPRA M.C.-MELOTTI A.-PATTAROZZI A.-
GATTI M.-BAJETTO A.-PORCILE C.-BARBIERI F.-FAVONI R.E.-LO CASTO M.-
ZONA G.-SPAZIANTE R.-FLORIO T.-CORTE G.
Different response of human glioma tumor initiating cells to
epidermal growth factor receptor kinase inhibitors.
J. Biol. Chem. 284:7138/7148, 2009
PubMed Abstract
PALMIERI D.-VALLI M.-VIGLIO S.-FERRARI N.-LEDDA B.-VOLTA C.-
MANDUCA P.
Osteoblasts extracellular matrix induces vessel like structures
through glycosylated collagen I.
Exp. Cell Res. 316:789/799, 2010 - Epub Dec 16, 2009
PubMed Abstract
POGGI A.-CATELLANI S.-GARUTI A.-PIERRI I.-GOBBI M.-ZOCCHI M.
Effective in vivo induction of NKG2D ligands in acute myeloid
leukaemias by all trans retinoic acid or sodium valproate.
Leukemia 23:641/648, 2009
PubMed Abstract
POGGI A.-CATELLANI S.-MUSSO A.-ZOCCHI M.
Gammadelta T lymphocytes producing IFNgamma and IL/17 in response
to Candida Albicans or mycobacterial antigens: possible
implications for acute and chronic inflammation.
Curr. Med. Chem. 16:4743/4749, 2009
PubMed Abstract
ROPOLO M.-DAGA A.-GRIFFERO F.-FORESTA M.-CASARTELLI G.-ZUNINO A.-
POGGI A.-CAPPELLI E.-ZONA G.-SPAZIANTE R.-CORTE G.-FROSINA G.
Comparative analysis of DNA repair in stem and nonstem glioma cell
cultures.
Mol. Cancer Res. 7:383/392, 2009
PubMed Abstract
SOGNO I.-VENE' R.-FERRARI N.-DE CENSI A.-IMPERATORI A.-NOONAN D.-
TOSETTI F.-ALBINI A.
Angioprevention with fenretinide: targeting angiogenesis in
prevention and therapeutic strategies.
Crit. Rev. Oncol. Hematol. 75:2/14, 2010 - Epub Dec 22, 2009
PubMed Abstract
SOGNO I.-VENE' R.-SAPIENZA C.-FERRARI N.-TOSETTI F.-ALBINI A.
Anti angiogenic properties of chemopreventive drugs: fenretinide
as a prototype.
Recent Results Cancer Res. 181:71/76, 2009
PubMed Abstract
TOSETTI F.-NOONAN D.-ALBINI A.
Metabolic regulation and redox activity as mechanisms for
angioprevention by dietary phytochemicals.
Int. J. Cancer 125:1997/2003, 2009
PubMed Abstract
VINCIGUERRA M.-CARROZZINO F.-PEYROU M.-CARLONE S.-MONTESANO R.-
BENELLI R.-FOTI M.
Unsaturated fatty acids promote hepatoma proliferation and
progression through downregulation of the tumor suppressor PTEN.
J. Hepatol. 50:1132/1141, 2009
PubMed Abstract
BIANCO R.-ROSA R.-DAMIANO V.-DANIELE G.-GELARDI T.-GAROFALO S.-
TARALLO V.-DE FALCO S.-MELISI D.-BENELLI R.-ALBINI A.-RYAN A.-
CIARDIELLO F.-TORTORA G.
Vascular endothelial growth factor receptor/1 contributes to
resistance to anti epidermal growth factor receptor drugs in human
cancer cells.
Clin. Cancer Res. 14:5069/5080, 2008
PubMed Abstract
CECCARELLI J.-DELFINO L.-ZAPPIA E.-CASTELLANI P.-BORGHI M.-FERRINI
S.-TOSETTI F.-RUBARTELLI A.
The redox state of the lung cancer microenvironment depends on the
levels of thioredoxin expressed by tumor cells and affects tumor
progression and response to prooxidants.
Int. J. Cancer 123:1770/1778, 2008
PubMed Abstract
LOMBARDI M.-TERRAZZANO G.-COSENTINI E.-GARGIULO L.-RISITANO A.-CAMERLINGO R.-SICA M.-AUFIERO D.-POGGI A.-PIROZZI G.-LUZZATTO L.-ROTOLI B.-NOTARO R.-ALFINITO F.-RUGGIERO G.
Paroxysmal nocturnal hemoglobinuria: significant association with
specific HLA/A, /B, /C, and /DR alleles in an italian population.
Hum. Immunol. 69:202/206, 2008
PubMed Abstract
MANDUCA P.-CASTAGNINO A.-LOMBARDINI D.-MARCHISIO S.-SOLDANO S.-
ULIVI V.-ZANOTTI S.-GARBI C.-FERRARI N.-PALMIERI D.
Role of MT1/MMP in the osteogenic differentiation.
Bone 44:251/265, 2009 - Epub Nov 5, 2008
PubMed Abstract
MONTEGHIRFO S.-TOSETTI F.-AMBROSINI C.-STIGLIANI S.-POZZI S.-
FRASSONI F.-FASSINA G.-SOVERINI S.-ALBINI A.-FERRARI N.
Antileukemia effects of xanthohumol in Brc/Abl transformed cells
involve nuclear factor/(kappa)B and p53 modulation.
Mol. Cancer Ther. 7:2692/2702, 2008
PubMed Abstract
PALMIERI D.-ASTIGIANO S.-BARBIERI O.-FERRARI N.-MARCHISIO S.-ULIVI
V.-VOLTA C.-MANDUCA P.
Procollagen I COOH terminal fragment induces VEGF/A and CXCR4
expression in breast carcinoma cells.
Exp. Cell Res. 314:2289/2298, 2008
PubMed Abstract
PATTERSON S.-CHAIDOS A.-NEVILLE D.-POGGI A.-BUTTERS T.-ROBERTS I.-
KARADIMITRIS A.
Human invariant NKT cells display alloreactivity instructed by
invariant TCR/CD1d interaction and killer Ig receptors.
J. Immunol. 181:3268/3276, 2008
PubMed Abstract
POGGI A.-CATELLANI S.-BRUZZONE A.-CALIGARIS F.-GOBBI M.-ZOCCHI M.
Lack of the leukocyte associated Ig/like receptor/1 expression in
high risk chronic lymphocytic leukaemia results in the absence of
a negative signal regulating kinase activation and cell division.
Leukemia 22:980/988, 2008
PubMed Abstract
POGGI A.-ZOCCHI M.
Role of bone marrow stromal cells in the generation of human
CD8(+) regulatory T cells.
Hum. Immunol. 69:755/759, 2008
PubMed Abstract
PONASSI R.-BIASOTTI B.-TOMATI V.-BRUNO S.-POGGI A.-MALACARNE D.-CIMOLI G.-SALIS A.-POZZI S.-MIGLINO M.-
DAMONTE G.-COZZINI P.-
SPYRAKI F.-CAMPANINI B.-BAGNASCO L.-CASTAGNINO N.-TORTOLINA L.-
MUMOT A.-FRASSONI F.-DAGA A.-CILLI M.-PICCARDI F.-MONFARDINI I.-
PERUGINI M.-ZOPPOLI G.-D'ARRIGO C.-PESENTI R.-PARODI S.
A novel Bim/BH3 derived Bcl/X(L) inhibitor. Biochemical
characterization, in vitro, in vivo and ex vivo anti leukemic
activity.
Cell Cycle 7:3211/3224, 2008
PubMed Abstract
VENE' R.-LARGHERO P.-ARENA G.-SPORN M.-ALBINI A.-TOSETTI F.
Glycogen synthase kinase 3beta regulates cell death induced by
synthetic triterpenoids.
Cancer Res. 68:6987/6996, 2008
PubMed Abstract
VIALE M.-PETRILLO G.-MACCAGNO M.-CASTAGNOLA P.-AIELLO C.-CORDAZZO
C.-MARIGGIO' M.-JADHAV S.-BIANCHI L.-LETO G.-RIZZATO E.-POGGI A.-
SPINELLI D.
Sensitivity of different resistant tumour cell lines to the two
novel compounds (2Z,4E)/2/methylsulfanyl/5/(1/naphthyl)/4/nitro/2,4
/pentadienoate and (1E,3E)/1,4/bis(2/naphthyl)/2,3/dinitro/1,3/buta
diene.
Eur. J. Pharmacol. 588:47/51, 2008
PubMed Abstract
ALBINI A.-FASSINA G.-NICOLO' M.-DELL'EVA R.-VENE' R.-CAMMAROTA R.-BARBERIS M.-NOONAN D.
Inhibition of a vascular ocular tumor growth by IL/12 gene transfer.
Clin. Exp. Metastasis 24:485/493, 2007
PubMed Abstract
ALBINI A.-NOONAN D.-FERRARI N.
Molecular pathways for cancer angioprevention.
Clin. Cancer Res. 13:4320/4325, 2007
PubMed Abstract
ALBINI A.-BENELLI R.
The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation.
Nat. Protoc. 2:504/511, 2007
PubMed Abstract
BENELLI R.
Aspirin, COX/2, and the risk of colorectal cancer. Letter.
N. Engl. J. Med. 357:824, 2007
DELL'AICA I.-NIERO R.-PIAZZA F.-CABRELLE A.-SARTOR L.-COLALTO C.-BRUNETTA E.-LORUSSO G.-BENELLI R.-ALBINI A.-CALABRESE F.-AGOSTINI C.-GARBISA S.
Hyperforin blocks neutrophil activation of matrix metalloproteinase/9, motility and recruitment, and restrains
inflammation triggered angiogenesis and lung fibrosis.
J. Pharmacol. Exp. Ther. 321:492/500, 2007
PubMed Abstract
DELL'EVA R.-AMBROSINI C.-VANNINI N.-PIAGGIO G.-ALBINI A.-FERRARI N.
AKT/NF/kappaB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies.
Cancer 110:2007/2011, 2007
PubMed Abstract
INDRACCOLO S.-PFEFFER U.-MINUZZO S.-ESPOSITO G.-RONI V.-MANDRUZZATO S.-FERRARI N.-ANFOSSO L.-DELL'EVA R.-NOONAN D.-
CHIECO BIANCHI L.-ALBINI A.-AMADORI A.
Identification of genes selectively regulated by IFNs in endothelial cells.
J. Immunol. 178:1122/1135, 2007
PubMed Abstract
NOONAN D.-BENELLI R.-ALBINI A.
Angiogenesis and cancer prevention: a vision.
Recent Results Cancer Res. 174:221/226, 2007
PubMed Abstract
POGGI A.-CATELLANI S.-FENOGLIO D.-BORSELLINO G.-BATTISTINI L.-
ZOCCHI M.
Adhesion molecules and kinases involved in gamma/delta T cells
migratory pathways: implications for viral and autoimmune diseases.
Curr. Med. Chem. 14:3166/3170, 2007
PubMed Abstract
POGGI A.-PREVOSTO C.-ZANCOLLI M.-CANEVALI P.-MUSSO A.-ZOCCHI M.
NKG2D and natural cytotoxicity receptors are involved in natural killer cell interaction with self antigen presenting cells and
stromal cells.
Ann. N.Y. Acad. Sci. 1109:47/57, 2007
PubMed Abstract
POGGI A.-ZANCOLLI M.-CATELLANI S.-BORSELLINO G.-BATTISTINI L.-ZOCCHI M.
Migratory pathways of gammadelta T cells and response to CXCR3 and CXCR4 ligands. Adhesion molecules involved and implications for
multiple sclerosis pathogenesis.
Ann. N.Y. Acad. Sci. 1107:68/78, 2007
PubMed Abstract
POGGI A.-ZOCCHI M.
Human natural killer lymphocytes through the engagement of natural cytotoxicity receptors and NKG2D can trigger self aggression.
Autoimmun. Rev. 6:295/299, 2007
PubMed Abstract
PREVOSTO C.-ZANCOLLI M.-CANEVALI P.-ZOCCHI M.-POGGI A.
Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell
lymphocyte interaction.
Haematologica 92:881/888, 2007
PubMed
Abstract
ROPOLO M.-DEGAN P.-FORESTA M.-D'ERRICO M.-LASIGLIE' D.-DOGLIOTTI E.-CASARTELLI G.-ZUPO S.-POGGI A.-FROSINA G.
Complementation of the oxidatively damaged DNA repair defect in Cockayne syndrome A and B cells by Escherichia coli
formamidopyrimidine DNA glycosylase.
Free Radic. Biol. Med. 42:1807/1817, 2007
PubMed Abstract
VENE' R.-ARENA G.-POGGI A.-D'ARRIGO C.-MORMINO M.-NOONAN D.-ALBINI A.-TOSETTI F.
Novel cell death pathways induced by N/(4/hydroxyphenyl)retinamide: therapeutic implications.
Mol. Cancer Ther. 6:286/298, 2007
PubMed Abstract
ALBINI A.-DELL'EVA R.-VENE' R.-FERRARI N.-BUHLER D.-NOONAN D.-FASSINA G.
Mechanisms of the antiangiogenic activity by the hop flavonoid xanthohumol: NF/kappaB and Akt as targets.
FASEB J. 20:527/529, 2006
PubMed Abstract
ALBINI A.-PFEFFER U.
A new tumor suppressor gene: invasion, metastasis, and angiogenesis as potential key targets.
J. Natl. Cancer Inst. 98:800/801, 2006
PubMed Abstract
ANFOSSO L.-EFFERTH T.-ALBINI A.-PFEFFER U.
Microarray expression profiles of angiogenesis related genes predict tumor cell response to artemisinins.
Pharmacogenomics J. 6:269/278, 2006
PubMed Abstract
BENELLI R.-LORUSSO G.-ALBINI A.-NOONAN D.
Cytokines and chemokines as regulators of angiogenesis in health and disease.
Curr. Pharm. Des. 12:3101/3115, 2006
PubMed Abstract
BISACCHI D.-ZHOU Y.-ROSEN B.-MUKHOPADHYAY R.-BORDO D.
Crystallization and preliminary crystallographic characterization of LmACR2, an arsenate/antimonate reductase from Leishmania major.
Acta Crystallogr. F 62:976/979, 2006
PubMed Abstract
CANTALUPPI V.-DEREGIBUS M.-BIANCONE L.-DEAMBROSIS I.-BUSSOLATI B.-ALBINI A.-CAMUSSI G.
The expression of CD154 by Kaposi's sarcoma cells mediates the anti apoptotic and migratory effects of HIV/1/Tat protein.
Int. J. Immunopathol. Pharmacol. 19:81/96, 2006
PubMed Abstract
CANTARELLA G.-RISUGLIA N.-DELL'EVA R.-LEMPEREUR L.-ALBINI A.-PENNISI G.-SCOTO G.-NOONAN D.-BERNARDINI R.
TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells.
Br. J. Cancer 94:1428/1435, 2006
PubMed Abstact
CARDINALI B.-DAMONTE G.-MELONE L.-SALIS A.-TOSETTI F.-ROCCO M.-PROFUMO A.
Identification of a new truncated form and deamidation products of fibrinopeptide B released by thrombin from human fibrinogen.
Thromb. Haemost. 96:302/308, 2006
PubMed Abstract
CATELLANI S.-POGGI A.-BRUZZONE A.-DADATI P.-RAVETTI J.-GOBBI M.-
ZOCCHI M.
Expansion of V(delta)1 T lymphocytes producing IL/4 in low grade
non Hodgkin lymphomas expressing UL/16 binding proteins.
Blood 109:2078/2085, 2007 - Epub Sep 14, 2006
PubMed Abstract
CONTINI P.-ZOCCHI M.-PIERRI I.-ALBARELLO A.-POGGI A.
In vivo apoptosis of CD8+ lymphocytes in acute myeloid leukemia
patients: involvement of soluble HLA/I and Fas ligand.
Leukemia 21:253/260, 2007 - Epub Dec 14, 2006
PubMed Abstract
DELL'EVA R.-AMBROSINI C.-MINGHELLI S.-NOONAN D.-ALBINI A.-FERRARI N.
The Akt inhibitor deguelin, is an angiopreventive agent also acting on the NF/(kappa)B pathway.
Carcinogenesis 28:404/413, 2007 - Epub Sep 4, 2006
PubMed Abstract
LARGHERO P.-VENE' R.-MINGHELLI S.-TRAVAINI G.-MORINI M.-FERRARI N.-PFEFFER U.-NOONAN D.-ALBINI A.-BENELLI R.
Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression.
Carcinogenesis 28:1008/1020, 2007 - Epub Nov 24, 2006
PubMed Abstract
PALEARI L.-TROMBINO S.-FALUGI C.-GALLUS L.-CARLONE S.-ANGELINI C.-SEPCIC K.-TURK T.-FAIMALI M.-NOONAN D.-ALBINI A.
Marine sponge derived polymeric alkylpyridinium salts as a novel tumor chemotherapeutic targeting the cholinergic system in lung tumors.
Int. J. Oncol. 29:1381/1388, 2006
PubMed Abstract
POGGI A.-ZOCCHI M.
Antigen presenting cells and stromal cells trigger human natural killer lymphocytes to autoreactivity: evidence for the involvement
of natural cytotoxicity receptors (NCR) and NKG2D.
Clin. Dev. Immunol. 13:325/336, 2006
PubMed Abstract
POGGI A.-ZOCCHI M.
HIV/1 Tat triggers TGF/beta production and NK cell apoptosis that is prevented by pertussis toxin B.
Clin. Dev. Immunol. 13:369/372, 2006
PubMed Abstract
POGGI A.-ZOCCHI M.
Mechanisms of tumor escape: role of tumor microenvironment in inducing apoptosis of cytolytic effector cells.
Arch. Immunol. Ther. Exp. (Warsz) 54:323/333, 2006
PubMed Abstract
RAPOSIO E.-GUIDA C.-BALDELLI I.-BENVENUTO F.-CURTO M.-PALEARI L.-FILIPPI F.-FIOCCA R.-ROBELLO G.-SANTI P.L.
Characterization and induction of human pre adipocytes.
Toxicol. In Vitro 21:330/334, 2007 - Epub Oct 5, 2006
PubMed Abstract
ROPOLO M.-GEROLDI A.-DEGAN P.-ANDREOTTI V.-ZUPO S.-POGGI A.-REED A.-KELLEY M.-FROSINA G.
Accelerated repair and reduced mutagenicity of oxidative DNA damage in human bladder cells expressing the E. coli FPG protein.
Int. J. Cancer 118:1628/1634, 2006
PubMed Abstract
SANGIORGI S.-CONGIU T.-MANELLI A.-DELL'EVA R.-NOONAN D.
The three dimensional microvascular architecture of the human Kaposi sarcoma implanted in nude mice: a SEM corrosion casting study.
Microvasc. Res. 72:128/135, 2006
PubMed Abstract
SCIELZO C.-CAMPOREALE A.-GEUNA M.-ALESSIO M.-POGGI A.-ZOCCHI M.-CHILOSI M.-CALIGARIS F.-GHIA P.
ZAP/70 is expressed by normal and malignant human B cell subsets of different maturational stage.
Leukemia 20:689/695, 2006
PubMed Abstract
SPINELLA F.-ROSANO' L.-DI CASTRO V.-DECANDIA S.-ALBINI A.-NICOTRA M.-NATALI P.-BAGNATO A.
Green tea polyphenol epigallocatechin/3/gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
Mol. Cancer Ther. 5:1483/1492, 2006
PubMed Abstract
TETTAMANTI G.-MALAGOLI D.-BENELLI R.-ALBINI A.-GRIMALDI A.-PERLETTI G.-NOONAN D.-DE EGUILEOR M.-OTTAVIANI E.
Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates.
Curr. Med. Chem. 13:2737/2750, 2006
PubMed Abstract
TOSETTI F.-NOONAN D.-ALBINI A.
Choking hypoxia inducible factor 1alpha: a novel mechanism for connective tissue growth factor inhibition of angiogenesis.
J. Natl. Cancer Inst. 98:946/948, 2006
PubMed Abstract
Per le pubblicazioni 2000-2005 del personale della struttura vedere gli
elenchi generali.
|
Presentazione della struttura